Previous Article | Next Article 
Applied and Environmental Microbiology, January 2001, p. 371-376, Vol. 67, No. 1
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.1.371-376.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rapid Method To Estimate the Presence of Secondary
Metabolites in Microbial Extracts
Richard E.
Higgs,*
James A.
Zahn,
Jeffrey D.
Gygi, and
Matthew D.
Hilton
Natural Products Research, Eli Lilly and
Company, Lilly Corporate Center, Indianapolis, Indiana 46285
Received 30 June 2000/Accepted 17 October 2000
 |
ABSTRACT |
Screening microbial secondary metabolites is an established method
to identify novel biologically active molecules. Preparation of
biological screening samples from microbial fermentation extracts requires growth conditions that promote synthesis of secondary metabolites and extraction procedures that capture the secondary metabolites produced. High-performance liquid chromatography (HPLC) analysis of fermentation extracts can be used to estimate the number of
secondary metabolites produced by microorganisms under various growth
conditions but is slow. In this study we report on a rapid
(approximately 1 min per assay) surrogate measure of secondary
metabolite production based on a metabolite productivity index computed
from the electrospray mass spectra of samples injected directly into a
spectrometer. This surrogate measure of productivity was shown to
correlate with an HPLC measure of productivity with a coefficient of
0.78 for a test set of extracts from 43 actinomycetes. This rapid
measure of secondary metabolite productivity may be used to identify
improved cultivation and extraction conditions by analyzing and ranking
large sets of extracts. The same methods may also be used to survey
large collections of extracts to identify subsets of highly productive
organisms for biological screening or additional study.
 |
INTRODUCTION |
Microbial extracts have been and
continue to be a productive source of new biologically active molecules
for drug discovery (2, 13). It is estimated that more than
30% of worldwide human pharmaceutical sales have compounds from
natural sources as their origin (12). With advances in
genomics and high-throughput screening (HTS) technology, many new
therapeutic targets are accessible for identifying pharmaceutical
agents. In addition to the historical practice of screening microbial
fermentation extracts for antibiotic activity, extracts can now
routinely be screened with a variety of new functional, receptor
binding, enzyme inhibition, and protein-protein interaction assays. HTS
formats used at many large pharmaceutical research organizations are,
however, generally incompatible with complex fermentation extracts. The
reasons for the incompatibility include nonspecific interference with
assay systems, cost in dollars and time to identify and dereplicate
active components from a complex mixture, and adverse physical
properties for automated liquid-handling equipment. Therefore,
additional investment in selection and preparation of fermentation
extracts is one strategy to align natural product drug discovery with
today's automated HTS assay systems. A typical approach to improve the
compatibility of fermentation extracts with HTS was recently reported
by Schmid et al., who described a multistage automated solid-phase
extraction (SPE) system (12).
To make the best use of finite resources in natural product discovery
organizations, it is important to identify collections of organisms
that produce secondary metabolites, culture conditions that generally
support secondary metabolite synthesis, and sample preparation
processes that retain secondary metabolites while maintaining
compatibility with HTS formats. It is well known that production of
secondary metabolites by microorganisms is influenced by fermentation
conditions. In a study of 29 Nodulisporium strains, Monaghan
et al. found that synthesis of secondary metabolites was directly
influenced by fermentation conditions and that there were differences
of up to 400-fold in the concentrations of secondary metabolites
between conditions (11). Additionally, Monaghan et al.
found that rare metabolites were consistently found in extracts
containing larger numbers of secondary metabolites. Yarbrough et al.
reported that several different growth conditions were required to
elicit secondary metabolite production in a set of 760 microorganisms
(16).
Given that additional investment is required to make fermentation
extracts compatible with modern HTS and that many fermentation extracts
may contain insufficient secondary metabolites to warrant such
investment, methods to characterize extracts from an industrial, high-throughput drug discovery perspective are needed. There are a
number of previously developed methods which use direct chemical measurement to classify microorganisms (5-8, 14). Most
previous studies focused on characterizing microorganisms by detecting the presence of known secondary metabolites. Frisvad et al. used high-performance liquid chromatography (HPLC) diode array detection and
flow injection analysis together with electrospray ionization mass
spectrometry (ES-MS) to detect secondary metabolites characteristic of
fungal strains responsible for spoilage of stored cereals (7, 8,
14). Feistner employed HPLC-ES-MS to determine metabolic profiles of strains of the bacterial genus Erwinia
(6). In our laboratories, Julian et al. developed an
HPLC-ES-MS system with automatic data processing that compares crude
fermentation extracts via an overall quantitative mixture similarity
measure (10).
The objective of this study was to investigate a rapid ES-MS method to
estimate the production of secondary metabolites in fermentation
extracts. If throughput were not a consideration, an HPLC-evaporative
light scattering detection (ELSD) analysis would provide a
quasi-universal estimate of the number of secondary metabolites
contained in an extract. ELSD is preferred due to the nonselective
nature of the detection of compounds. Our goal was to identify a rapid
ES-MS surrogate method for secondary metabolite production whose
results correlate with the results of HPLC-ELSD analysis and provide
some chemical information concerning the molecular and fragment ions of
secondary metabolites. With a rapid estimator of secondary metabolite
productivity, large collections of fermentation extracts could be
characterized. Such a characterization would be a useful tool for
identifying growth conditions that support synthesis of secondary
metabolites. A tool for rapid characterization of extracts would also
be a useful survey tool for identifying productive organisms for more
detailed chemical analysis, purification, and biological screening.
 |
MATERIALS AND METHODS |
Organisms and cultivation.
Broth cultures of 43 actinomycetes (17) were started from cryogenic stocks in a
vegetative medium that contained (per liter) 30 g of tryptic soy
broth (Difco Laboratories, Detroit, Mich.), 3 g of yeast extract (Sigma
Chemical Co., St. Louis, Mo.), 2 g of MgSO4, 5 g
of glucose, and 4 g of maltose. At the mid-log phase, 60 µl
(~0.4% inoculum) of each vegetative culture was transferred into 12 ml of a complex growth medium containing (per liter) 10 g of
glucose, 40 g of potato dextrin (Avedex, Keokuk, Iowa), 15 g of
cane molasses (Cargill, Minneapolis, Minn.), 10 g of Hy-case amino
(Sheffield Products, Norwich, N.Y.), 1 g of MgSO4, and
2 g of CaCO3. The fermentation vessel consisted of a
rectangular Axid (Eli Lilly and Co., Indianapolis, Ind.) polypropylene
bottle that was approximately 3.5 cm long by 4.25 cm wide by 6 cm high. The closure used for each small shake flask fermentation bottle consisted of a
-irradiated, vented polypropylene cap lined with a
gas-permeable membrane (Performance Systematix, Inc., Caledonia, Mich.). Submerged fermentations were incubated at 30°C for 7 days on
an orbital shaker (stroke length, 2 in.) at 110 rpm. Fermentations were
prepared for chemical analysis by solublization and extraction of
secondary metabolites by the addition of an equal volume of absolute
ethanol to the fermentation vessels. Fermentation vessels containing
ethanol were agitated for 2 h on an orbital shaker (stroke length,
2 in.) at 200 rpm, and then the contents were allowed to settle for
16 h at 4°C. The ethanol extracts were then filtered through a
100-µm-pore-size polypropylene screen and transferred to 96-well
plates for solid-phase extraction.
Extract bioassay.
Gram-positive bactericidal bioassays were
performed by applying 6-µl portions of ethanol-solublized
fermentation broth to 0.25-in.-diameter sterile paper discs. The dried
discs were placed on seeded agar assay plates containing
Micrococcus luteus ATCC 9341 (Food and Drug Administration
strain PCI1001) and were incubated for 2 days at 37°C.
SPE of actinomycete extracts.
Nonpolar components were
enriched from 0.7-ml samples of the actinomycete extracts by SPE on
Empore octadecyl SD high-performance extraction disc plates (3M
Company, St. Paul, Minn.). The SPE stationary phase was conditioned for
use by sequential washing with 2 ml of distilled H2O, with
2 ml of methanol, and finally with 2 ml of 1 mM ammonium acetate (pH
5.5) in distilled H2O. The ethanol was removed from 0.7-ml
samples under a vacuum (
80 kPa) at 20°C for 16 h. The residual
aqueous material was resuspended to a total volume of 0.5 ml with 1 mM
ammonium acetate (pH 5.5) and loaded on the conditioned SPE stationary
phase. The SPE stationary phase was washed with 5 ml of 1 mM ammonium
acetate (pH 5.5), and the fraction analyzed, enriched for relatively
nonpolar metabolites, was eluted with 0.7 ml of a 70%
acetonitrile-30% (vol/vol) methanol solution which contained 6.5 mM
ammonium acetate (pH 5.5). The secondary metabolite-containing fraction
was transferred into microwell plates for chemical analyses.
Chemical analyses.
Chemical analysis of SPE eluates was
performed by (HPLC-ES-MS-ELSD) as described by Julian et al. and by
direct-infusion ES-MS. For the HPLC-ES-MS-ELSD experiments,
ethanol-solublized analytes (50 µl) were separated on a Novapak
C18 analytical column (3.9 by 150 mm) by using a 30-min
linear gradient from 2% methanol-15 mM ammonium acetate to 95%
methanol-15 mM ammonium acetate at a flow rate of 710 µl
min
1. The column effluent was split between a Finnigan
Navigator (160 µl min
1) equipped with a Finnigan
electrospray source and a Sedex 55 evaporative light scattering
detector (570 µl min
1; Sedere, Alfortville, France) in
order to provide qualitative and quantitative data, respectively. The
lower limit of detection for the evaporative light scattering detector
was estimated to be approximately 2 µg/ml based on dilution of a
standard mixture. UV and visible light absorption spectra (220 to 550 nm) were acquired with a Hewlett-Packard series 1100 photodiode array
spectrophotometer by using column effluent prior to analysis by
evaporative light scattering. The electrospray source was switched
between positive ion mode and negative ion mode at 0.4-s intervals to
acquire both positive and negative ion spectra. During data
acquisition, the mass spectrometer probe voltage was maintained at 3.6 kV, the cone voltage was maintained at 35 V, the source temperature was kept at 180°C, and the drying gas flow rate was 500 liters · h
1. A standard solution consisting of
2-amino-6-chloropurine (50 µg/ml), caffeine (50 µg/ml),
m-cresol purple (50 µg/ml), tylosin (25 µg/ml), and
spinosyn A (50 µg/ml) was injected at the beginning of the analysis
and then after every 10th experimental sample to assess instrument
stability and performance.
Direct-infusion ES-MS was performed with SPE-treated samples by using a
Finnigan Navigator mass spectrometer equipped with a Finnigan
electrospray source. The mass spectrometer parameters were identical to
those described above for the HPLC-ES-MS analysis. Exactly 20 µl of
a sample was injected into the carrier gas stream of the electrospray
source at a flow rate of 160 µl min
1 through a Gilson
215 liquid handler and a Gilson 819 injection valve actuator by using a
Shimadzu LC-10ADVP liquid chromatograph pump. The standard solution
described above was injected at the beginning of the analysis and after
every 10th experimental sample to assess instrument stability and
performance. The time between injections was approximately 60 s.
Data collected by the mass spectrometer data system were converted to
the netCDF file format (
15) and transferred to a Sun
compute server for analysis. The C programming language was used
to
automate execution of the algorithms described in this
paper.
 |
RESULTS AND DISCUSSION |
Analytical HPLC and collection of fractions of biologically active
fermentation extracts are routinely done by natural product drug
discovery groups to identify the active component(s) in a complex
mixture (1). We coupled these familiar analytical
techniques with automated algorithms to identify organisms that
produced secondary metabolites under specific growth conditions. In
this study we analyzed 43 actinomycete extracts by using a 30-min
HPLC-ELSD method to identify the numbers and relative amounts of
secondary metabolites present in ethanol extracts of fermentation
broth. SPE of ethanol extracts on C18 activated silica was
employed to reduce the polar components, presumably including salts,
cellular macromolecules, spent medium components, and other cellular
debris present in the ethanol extracts. Despite some influence of
solvent concentration and the molecular structure of an analyte, ELSD is generally considered a quasi-universal detector of the quantity of
an analyte in a sample (3, 9). For the growth conditions considered here, we observed a broad range of apparent secondary metabolite production in organisms. Some extracts contained no detectable metabolites (Fig. 1d), while
others contained many (Fig. 1f). In order to monitor detector
sensitivity and column performance, a standard mixture consisting of
five known compounds at known concentrations was injected between sets
of 10 extracts. The mean natural log (loge) of the area
under the HPLC-ELSD chromatogram for the control injections was 11.0 with a coefficient of variation (COV) of 1.3%, indicating that
sufficient reproducibility could be achieved in automated analyses of
relatively complex samples. Because of the exponential nature of ELSD,
a log transform was done in order to work in units that are linearly
related to the log of the concentration of a solute (3).
While the 30-min HPLC-ELSD method is generally effective for
identifying the numbers and approximate concentrations of secondary
metabolites present in fermentation extracts, the throughput is not
sufficient for studies in which assessment of larger numbers of
organisms is required. Additionally, the HPLC-ELSD method provides no
information regarding the chemical composition of the metabolites
present in an extract. For these reasons we investigated a
higher-throughput ES-MS method that we believed had the potential to be
a surrogate for the HPLC-ELSD method for estimating secondary
metabolite production. In addition to serving as a rapid surrogate for
the HPLC-ELSD method, the mass fragments from the rapid ES-MS method
provided information about the chemical compositions of compounds in an extract.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Positive ion ES-MS spectra and HPLC-ELSD chromatograms
for the actinomycete extract with the minimum positive ES-MS
productivity index (1,607) (a and d), the actinomycete extract with the
positive ES-MS productivity index nearest the median (2,277) (b and e),
and the actinomycete extract with the maximum positive ES-MS
productivity index (5,852) (c and f).
|
|
Analysis of direct-infusion ES-MS data and algorithm
description.
We found that simple summation of peak intensities in
the ES-MS spectra determined for the extracts was only marginally
effective at predicting the productivities of broths as benchmarked
against the HPLC-ELSD analyses (data not shown). In response, we
examined preprocessing steps to improve the prediction. Mass spectra
are commonly binned by partitioning the m/z range
into fixed, equal-size partitions and assigning each ion intensity to
the appropriate partition or bin. The sum of all ion intensities that
fall within each m/z bin is used as the intensity
value for the bin. This simple binning scheme works well as long as the
m/z values of ions do not lie near a bin
boundary. For ions with m/z values near a bin
boundary, small differences in the m/z values
estimated by mass spectrometry can place the same ion from two samples
into different bins, which results in errors when two binned spectra are compared. To address this problem, an overlapping binning scheme
was developed in order to assign the intensity of an ion to two bins if
the m/z value was within an overlap region
centered at the bin boundary. The proportion of intensity assigned to
each bin for an ion falling within an overlap region was scaled to be
linearly proportional to the difference between the measured m/z value and the bin boundary. Thus, all
examples presented in this paper are based on spectra that were
preprocessed by binning the measured intensities into 5,800 m/z bins between 150 and 1,600 atomic mass units
(amu) with a 0.2-amu bin overlap region forming a vector of fixed
length for each extract analyzed. This transformation of raw data to
vectors allowed spectral averaging and background subtraction in order
to obtain an improved estimate of fermentation productivity.
A background corrected mass spectrum was computed by averaging all of
the binned spectra within a selected signal window and
subtracting the
average of the binned spectra within a defined
background window. For
the ES-MS method, the signal window of
interest included scans detected
between 0.15 and 0.60 min after
injection. The background region was
defined by scans obtained
between 0.0 and 0.10 min after
injection.
Fermentation growth media often contain numerous complex components to
support growth and expression of secondary metabolites.
Many times
these medium components are not fully consumed and
may therefore remain
in broth media at harvest time. In order
to reduce any systematic bias
introduced by medium components
in our analysis, the averaged and
background subtracted spectrum
from an uninoculated medium blank was
subtracted from the binned,
background subtracted mass spectrum of each
extract. Ion counts
less than zero following this subtraction were
given a value of
zero. This medium subtraction strategy works well for
unaltered
medium components in an extract but would not work well for
components
transformed by an
organism.
Following background and medium subtraction, the productivity of an
extract was estimated by examining the number and intensity
of ions in
the preprocessed spectrum. Extracts containing more
secondary
metabolites were observed to have more ions present
in their
preprocessed mass spectra (Fig.
1). Metabolites present
at higher
concentrations were observed to produce larger ion signals.
We believe
that any measure of overall productivity should consider
both the
number of ions and their intensity. A simple ion counting
procedure was
developed to capture information about the number
and intensity of the
ions detected. For each extract, the number
of ions with intensities
above an intensity threshold value was
recorded. The threshold was then
increased, and the number of
ions with intensities above the new
threshold value were added
to the initial count. This process was
repeated until the threshold
value reached a specified maximum value.
This procedure is represented
graphically in Fig.
2. For the productivity indices reported
for
the extracts described here we used 1,000 intensity threshold
values between a minimum intensity threshold value of zero and
a
maximum intensity threshold value of 10
6 counts. Analysis
after repeated injections of the growth medium
indicated that a six- to
sevenfold decrease in productivity index
for the growth medium was
obtained when medium subtraction was
included. Productivity indices
were computed independently for
positive ion mass spectra and negative
ion mass spectra. The mathematical
manipulations of mass spectra
described above were coded into
a C language computer program to
facilitate automated, high-throughput
analysis of spectra.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Background- and medium-subtracted positive ion ES mass
spectrum of a solid-phase actinomycete extract. The productivity index
was computed by adding all of the ions above a series of ion count
thresholds. In this example 12 thresholds are shown as horizontal
dotted lines, resulting in a productivity index of 57.
|
|
System reproducibility.
Mass spectrometer sensitivity was
monitored throughout the analysis of experimental samples due to the
potential for variable sensitivity caused by the plugging and coating
of surfaces in the instruments. Detector sensitivity was monitored by
bracketing sets of 10 extract injections with injections of the
standard mixture. The background-corrected positive ion mass spectrum
of the standard mixture (Fig. 3) had a
mean positive ion productivity index of 3,490 with a COV of 7.5%
(n = 12). The mean negative ion productivity index for
the control injections was 59.6 with a COV of 19.7% (n = 12). The higher variability observed in the negative ion mode was
attributed to the overall lower sensitivity of the mass spectrometer in
the negative ion detection mode. For large studies conducted with
multiple instruments or over long periods of time, the productivity
indices for the bracketing controls may be used to scale the
productivity indices of extracts.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Direct-infusion positive ES-MS of control mixture
containing 2-amino-6-chloropurine (50 µg/ml), caffeine (50 µg/ml),
m-cresol purple (50 µg/ml), tylosin (25 µg/ml), and
spinosyn A (50 µg/ml). [M+H]+ ions and adduct ions are
shown for each analyte in the control mixture.
|
|
Comparison of the rapid ES-MS and HPLC-ELSD methods.
Examination of the positive ion mass spectrum and its associated
HPLC-ELSD chromatogram for the extracts with minimum, median, and
maximum positive ion productivity illustrated the visual correlation between the positive ion productivity and the HPLC-ELSD chromatogram (Fig. 1). To quantitatively assess this correlation, the natural log of
the area under the HPLC-ELSD chromatogram was computed for each
solid-phase extract and compared to positive and negative ion
productivity indices via Pearson's correlation coefficient. Additionally, the positive and negative ion productivity indices were
combined into a single composite productivity index by first linearly
scaling the positive and negative ion productivity indices to be on the
[0, 1] scale and then adding the two scaled indices. Scaling was
required due to the large differences in productivity index values
between the positive and negative modes. Pearson correlation
coefficients for comparisons between the positive ion, negative ion,
and combined productivity indices and the loge HPLC-ELSD
areas under the curve are shown in Table
1. A 90% confidence interval for each
correlation coefficient was estimated by using the bias-corrected and
accelerated (BCa) method (10,000 bootstrap samples)
described by Efron and Tibshirani (4). The bootstrap method is used as an alternative to Fisher's transformation of the
correlation coefficient for estimating confidence intervals (mean ± 1.96 × standard error of the transformed data). Bootstrap confidence intervals are estimated by drawing many random samples (with
replacement) from the original data, computing the correlation coefficient for each random sample, and then examining the distribution (histogram) of the correlation coefficients. Confidence intervals estimated with the bootstrap method are essentially identical to those
estimated by using Fisher's transformation. The combined productivity
index correlated best with the HPLC-ELSD measure of secondary
metabolite productivity with a correlation coefficient (rc) of 0.78 (Fig.
4). While the positive and negative ion
productivity indices had correlation coefficients that were
approximately equal (r+ = 0.72 and
r
= 0.70, respectively), the length of
the 90% confidence interval for the correlation coefficient was much
narrower for positive ion data (0.24 for the positive ion data and 0.51 for the negative ion data). A bootstrap hypothesis testing procedure
(4) using 10,000 bootstrap samples was used to test the
one-sided hypotheses:
|
|
|
|
|
|
Based on these hypothesis tests, the combined productivity
index appears to be better than the negative and positive ion
productivity indices at the approximate achieved significance
levels of
0.13 and 0.21, respectively (Table
2).
The approximate
significance levels were estimated by dividing the
number of bootstrap
samples for which the alternative hypothesis was
false by the
total number of bootstrap samples. There appeared to be no
significant
difference between the correlations of the positive and
negative
ion productivity indices with the HPLC-ELSD benchmark
(approximate
achieved significance level, 0.40). A direct-infusion
ES-MS analysis
of the crude extracts, bypassing the SPE step, was done
in order
to assess the correlation of a simplified sample preparation
method
with an HPLC-ELSD benchmark. The correlation coefficient for
comparisons
between the combined positive and negative ion productivity
indices
for the non-SPE approach and the HPLC-ELSD benchmark
(
rc,nospe)
was 0.68, a value somewhat lower than
the correlation coefficient
obtained when the SPE step preceded the
ES-MS analysis. A one-sided
test of the hypothesis H
0:
rc =
rc,nospe,
H
A:
rc >
rc,nospe was
rejected at the approximate
achieved significance level of 0.08
with 10,000 bootstrap samples,
indicating only marginal improvement
with SPE.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Correlation coefficients and their 90% BCa
bootstrap confidence intervals for comparisons between
r+, r , and
rc and loge HPLC-ELSD area under the
curve
|
|

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Area under the HPLC-ELSD chromatogram versus the
combined positive and negative ion productivity index for 43 actinomycete SPE extracts. The correlation coefficient is 0.78 with a
90% BCa bootstrap confidence interval of [0.63, 0.91].
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Summary of bootstrap hypothesis testing procedure
comparing the surrogate secondary metabolite indices to the
HPLC-ELSD measure of productivitya
|
|
A bioassay approach to estimating the production of secondary
metabolites is one alternative to the chemical screening methods
considered in this study. For example, an antimicrobial bioassay
or a
battery of antimicrobial assays could be used to identify
organisms
producing antibacterial secondary metabolites. A major
disadvantage of
a bioassay profiling approach is that estimation
of secondary
metabolites is restricted to organisms producing
compounds active in
the bioassay used and may be dominated by
common antibacterial
metabolites. The rapid ES-MS chemically based
profiling approach is
more general in that its only restriction
is that compounds must be
detectable by either positive or negative
ion electrospray ionization.
To compare the effectiveness of an
antimicrobial measure of secondary
metabolite production, gram-positive
antibiotic bioassays were
performed for each of the actinomycete
extracts. Eleven of the 43 actinomycete extracts exhibited non-zero
zones of inhibition (data not
shown). The correlation coefficient
for a comparison between zone of
inhibition and the HPLC-ELSD
benchmark was 0.25, suggesting that
several extracts contained
secondary metabolites that exhibited no
detectable antimicrobial
activity in a single plate assay. It should be
emphasized that
only one bioassay was conducted for illustration
purposes. A higher
correlation coefficient might be obtained with a
battery of antimicrobial
assays, although in practice, this technique
would be limited
to detecting only metabolites with antimicrobial
activity.
Collection of microbial cultures by pharmaceutical research
organizations generally results in large numbers of uncharacterized
organisms. While some biological classification is useful, direct
assessment of secondary metabolites provides highly relevant
information
for drug discovery applications. Here we report on a rapid
ES-MS
method (~50 samples/h) to estimate the presence of secondary
metabolites
produced by microorganisms. The effectiveness of this rapid
method
was assessed relative to the effectiveness of HPLC-ELSD
quantitation
of secondary metabolites contained in ethanol extracts
from 43
different actinomycetes. We observed generally good agreement
between an HPLC-ELSD method for quantifying secondary metabolite
production and the approximately 25-fold-more-rapid ES-MS method
(correlation coefficient for combined positive and negative ion
ES-MS
data, 0.78). Resampling-based hypothesis testing procedures
indicated that the combined ES-MS productivity index is better
than the
individual positive or negative ionization productivity
indices with
apparent significance levels of 0.13 and 0.21, respectively.
Monitoring
periodic injections of a control mixture revealed that
extracts from
microbial fermentation can be analyzed reliably
by a high-throughput
mass spectrometry
system.
The potential applications of a rapid estimator of secondary metabolite
production in modern natural product drug discovery
are severalfold.
Researchers interested in identifying secondary
metabolite-eliciting
growth conditions for a large, uncharacterized
collection of
microorganisms may find this rapid tool useful for
evaluating multiple
growth conditions with statistically large
numbers of microorganisms
(
17). Given a defined set of growth
conditions, this tool
may also prove to be useful for identifying
particularly productive
microorganisms for the construction of
a screening library. Organisms
classified as unproductive by this
method could be recycled for
additional growth condition development
to fully realize the potential
of a culture collection for drug
discovery
applications.
 |
ACKNOWLEDGMENTS |
We thank Mike Goodwin, John Scheuring, Dale Duckworth, and Matt
Clemens for insightful discussions and for analysis of actinomycete extracts by ES-MS and HPLC-ES-MS-ELSD. We are also grateful to Steve
Larsen for assistance with SPE of the actinomycete fermentations.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Lilly Corporate
Center, Drop Code 1533, Indianapolis, IN 46285. Phone: (317) 276-1536. Fax: (317) 276-5281. E-mail: higgs{at}lilly.com.
Present address: National Swine Research Center, USDA, ARS, Ames,
IA 50011.
 |
REFERENCES |
| 1.
|
Cordell, G. A., and Y. G. Shin.
1999.
Finding the needle in the haystack. The dereplication of natural product extracts.
Pure Appl. Chem.
71:1089-1094[CrossRef].
|
| 2.
|
Cragg, G. M.,
D. J. Newman, and K. M. Snader.
1997.
Natural products in drug discovery and development.
J. Nat. Prod. (Lloydia)
60:52-60[CrossRef][Medline].
|
| 3.
|
Dreux, M.,
M. Lafosse, and L. Morin-Allory.
1996.
The evaporative light scattering detector: a universal instrument for non-volatile solutes in LC and SFC.
LC-GC Int.
9:148-153.
|
| 4.
|
Efron, B., and R. J. Tibshirani.
1993.
An introduction to the bootstrap.
Chapman and Hall, New York, N.Y.
|
| 5.
|
Erhard, M.,
H. von Dohren, and P. Jungblut.
1997.
Rapid typing and elucidation of new secondary metabolites of intact cyanobacteria using MALDI-TOF mass spectrometry.
Nat. Biotechnol.
15:906-909[CrossRef][Medline].
|
| 6.
| Feistner, G. J. 1994. Profiling of bacterial
metabolites by liquid chromatography-electrospray mass spectrometry: a
perspective. Am. Lab. (Fairfield, Conn.)
1994(September):32L-32Q.
|
| 7.
|
Filtenbort, O.,
J. C. Frisvad, and J. A. Svendsen.
1983.
Simple screening method for molds producing intracellular mycotoxins in pure cultures.
Appl. Environ. Microbiol.
45:581-585[Abstract/Free Full Text].
|
| 8.
|
Frisvad, J. C.,
O. Filtenborg, and U. Thrane.
1989.
Analysis and screening for mycotoxins and other secondary metabolites in fungal cultures by thin-layer chromatography and high-performance liquid chromatography.
Arch. Environ. Contam. Toxicol.
18:331-335[CrossRef][Medline].
|
| 9.
|
Guichon, G.,
A. Moysan, and C. Holley.
1988.
Influence of various parameters on the response factors of the evaporative light scattering detector for a number of non-volatile compounds.
J. Liq. Chromatogr.
11:2547-2570[CrossRef].
|
| 10.
|
Julian, R. K.,
R. E. Higgs,
J. D. Gygi, and M. D. Hilton.
1998.
A method for quantitatively differentiating crude natural extracts using high-performance liquid chromatography-electrospray mass spectrometry.
Anal. Chem.
70:3249-3254[CrossRef].
|
| 11.
|
Monaghan, R. L.,
J. D. Polishook,
V. J. Pecore,
G. F. Bills,
M. Nallin-Omstead, and S. L. Streicher.
1995.
Discovery of novel secondary metabolites from fungi is it really a random walk through a random forest?
Can. J. Bot.
73(Suppl. 1):S925-S931.
|
| 12.
|
Schmid, I.,
I. Sattler,
S. Grabley, and R. Thiericke.
1999.
Natural products in high throughput screening: automated high-quality sample preparation.
J. Biomol. Screening
4:15-25[Abstract/Free Full Text].
|
| 13.
|
Shu, Y.
1998.
Recent natural products based drug development: a pharmaceutical industry perspective.
J. Nat. Prod. (Lloydia)
61:1053-1071[CrossRef][Medline].
|
| 14.
|
Smedsgard, J., and J. C. Frisvad.
1996.
Using direct electrospray mass spectrometry in taxonomy and secondary metabolite profiling of crude fungal extracts.
J. Microbiol. Methods
25:5-17.
|
| 15.
|
Stranz, D.,
S. Campbell,
R. Christopher,
J. Watt, and D. Zakett.
1993.
Data interchange for mass spectrometry, version 1.0.1.
Analytical Instrument Association.
|
| 16.
|
Yarbrough, G. G,
D. P. Taylor,
R. T. Rowlands,
M. S. Crawford, and L. L. Lasure.
1993.
Screening microbial metabolites for new drugs: theoretical and practical issues.
J. Antibiot.
46:535-544[Medline].
|
| 17.
|
Zahn, J. A.,
R. E. Higgs, and M. D. Hilton.
2001.
Use of direct-infusion electrospray mass spectrometry to guide empirical development of improved conditions for expression of secondary metabolites from actinomycetes.
Appl. Environ. Microbiol.
67:377-386[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, January 2001, p. 371-376, Vol. 67, No. 1
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.1.371-376.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zahn, J. A., Higgs, R. E., Hilton, M. D.
(2001). Use of Direct-Infusion Electrospray Mass Spectrometry To Guide Empirical Development of Improved Conditions for Expression of Secondary Metabolites from Actinomycetes. Appl. Environ. Microbiol.
67: 377-386
[Abstract]
[Full Text]